SCD5 is also subjected to regulation by HIF2 in VHL-deficient ccRCC cells, as pharmacological inhibition of HIF2α in RCC4 and 786-O cells restored SCD5 expression (Figure 4). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.